Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers–ORCHESTRA project
G Collatuzzo, G Visci, FS Violante, S Porru… - Frontiers in …, 2022 - frontiersin.org
… immune response to COVID-19 vaccines at 6 months … to COVID-19 vaccination (19), the
predictors of immunological response to vaccination (20), as well as the predictors of COVID-19 …
predictors of immunological response to vaccination (20), as well as the predictors of COVID-19 …
Determinants of Anti-S Immune Response at 9 Months after COVID-19 Vaccination in a Multicentric European Cohort of Healthcare Workers—ORCHESTRA Project
… addressing various aspects of the COVID-19 pandemic, showed a … of COVID-19 antibody
titers to 9 months after the first vaccine … HCW-related and vaccination-related characteristics. …
titers to 9 months after the first vaccine … HCW-related and vaccination-related characteristics. …
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
F Götzinger, B Santiago-García… - The Lancet Child & …, 2020 - thelancet.com
… capture key data on COVID-19 in children in Europe on a large scale, to aid physicians in
Europe and in other geographical locations with service planning and allocation of resources. …
Europe and in other geographical locations with service planning and allocation of resources. …
SARS-CoV-2 breakthrough infections: incidence and risk factors in a large European multicentric cohort of health workers
S Porru, MGL Monaco, G Spiteri, A Carta, MD Pezzani… - Vaccines, 2022 - mdpi.com
… their determinants in a large European cohort of more than 60,000 health workers. Methods:
A multicentric retrospective cohort study, involving 12 European centers, was carried out …
A multicentric retrospective cohort study, involving 12 European centers, was carried out …
… COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - thelancet.com
… response to vaccination with the mRNA-1273 COVID-19 vaccine. The vaccine is also safe in
… As of June 28, 2021, one patient in cohort C had been diagnosed with COVID-19, 23 days …
… As of June 28, 2021, one patient in cohort C had been diagnosed with COVID-19, 23 days …
[HTML][HTML] Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort …
P Nordström, M Ballin, A Nordström - … Regional Health–Europe, 2021 - thelancet.com
… In this study, heterologous Covid-19 vaccination using ChAdOx1 nCoV-19 as a first dose …
67% to 79% effectiveness against symptomatic Covid-19-infection. The effectiveness of the two …
67% to 79% effectiveness against symptomatic Covid-19-infection. The effectiveness of the two …
Multimorbidity and serological response to SARS-CoV-2 nine months after 1st vaccine dose: European cohort of healthcare workers—Orchestra project
… European Medicines Agency (EMA) have issued a joint statement regarding adapted COVID-19
vaccines … ORCHESTRA comprises a prospective multicenter cohort including more than …
vaccines … ORCHESTRA comprises a prospective multicenter cohort including more than …
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre …
… We aimed to determine the factors associated with vaccine coverage for both vaccines and
documented the vaccine effectiveness of the BNT162b2 mRNA vaccine in a cohort of health-…
documented the vaccine effectiveness of the BNT162b2 mRNA vaccine in a cohort of health-…
COVID-19 vaccination did not increase the risk of potentially related serious adverse events: 18-month cohort study in an Italian province
… In the infected population, any dose of vaccine was associated with … In conclusion, COVID-19
vaccination was not associated with … to evaluate the long-term safety of COVID-19 vaccines. …
vaccination was not associated with … to evaluate the long-term safety of COVID-19 vaccines. …
The role of COVID-19 vaccines in preventing post COVID-19 thromboembolic and cardiovascular complications: a multinational cohort study
… association between COVID-19 vaccination and the risk of acute and subacute COVID-19
cardiac and … data sources from 3 European countries to assess the overall effect of COVID-19 …
cardiac and … data sources from 3 European countries to assess the overall effect of COVID-19 …